Issue 1/2021
Content (15 Articles)
Want to Improve Public Health Access? Let’s Start with the Basics: Measuring Efficiency Correctly
Antony Andrews
Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions
Melissa H. Roberts, Gary T. Ferguson
Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Rachel Houten, Janette Greenhalgh, James Mahon, Sarah Nevitt, Sophie Beale, Angela Boland, Tosin Lambe, Yenal Dundar, Eleanor Kotas, Joanne McEntee
Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis
Machaon Bonafede, Rina Mehta, Gilwan Kim, Ila Sruti, Marc Tian, Corey Pelletier, Neil Goldfarb
Economic Burden of Chronic Obstructive Pulmonary Disease Patients in Malaysia: A Longitudinal Study
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Sadia Shakeel, Ong Siew Chin, Irfhan Ali Bin Hyder Ali, Jaya Muneswarao, Rabia Hussain
Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder
Greta Lozano-Ortega, Carol R. Schermer, David R. Walker, Shelagh M. Szabo, Basia Rogula, Alison M. Deighton, Katherine L. Gooch, Noll L. Campbell
Investigation of Factors Considered by Health Technology Assessment Agencies in Eight Countries
Akira Yuasa, Naohiro Yonemoto, Sven Demiya, Chihiro Foellscher, Shunya Ikeda
Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
Jefferson Antonio Buendía, Diana Guerrero Patiño
The Value of a New Diagnostic Test for Prostate Cancer: A Cost-Utility Analysis in Early Stage of Development
Adam Fridhammar, Ulrika Axelsson, Ulf Persson, Anders Bjartell, Carl A. K. Borrebaeck
Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
Mohamed I. Elsaid, You Li, Carolyn Catalano, Carlos D. Minacapelli, Kapil Gupta, Vinod K. Rustgi
Do Rural Residents in China Understand EQ-5D-5L as Intended? Evidence From a Qualitative Study
Fan Yang, Shan Jiang, Xiao-ning He, Hong-chao Li, Hong-yan Wu, Tian-tian Zhang, Jing Wu
Costs and Extra Length of Stay because of Neonatal Bloodstream Infection at a Teaching Hospital in Ghana
Ama Pokuaa Fenny, Evans Otieku, Kwaku Appiah-Korang Labi, Felix Ankomah Asante, Ulrika Enemark
Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
Christine M. Cramer-van der Welle, Bas J. M. Peters, Maarten J. Deenen, Franz M. N. H. Schramel, Ewoudt M. W. van de Garde
Hospital Length of Stay for Patients with Severe COVID-19: Implications for Remdesivir’s Value
Michaela R. Anderson, Peter B. Bach, Matthew R. Baldwin
Gaining Patient Input on Naming a Novel Patient-Reported Outcome Instrument in Chronic Weight Management
Heather Rozjabek, John Fastenau, Samara Bennett, Lydia Min-Joo Lee